Marché de la toux chronique – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00011584
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 180
Buy Now

Le marché de la toux chronique devrait atteindre 9 854,8 millions de dollars US d'ici 2027 contre 5 430,0 millions de dollars US en 2019 ; on estime qu'elle croîtra à un TCAC de 7,8 % de 2020 à 2027.



La toux chronique est définie comme une toux persistante qui dure jusqu'à 6 à 8 semaines. Il affecte considérablement la vie des patients en interrompant le sommeil, en créant une sensation de vomissement, des étourdissements et même des fractures des côtes. Il est dû à de multiples raisons telles que les infections, l'asthme et le reflux gastro-oesophagien (RGO). La croissance du marché de la toux chronique est attribuée à des facteurs tels que l'incidence croissante de la toux chronique et le développement croissant de produits pour traiter la toux chronique devrait stimuler la croissance du marché. Cependant, les rappels de produits sont le principal facteur qui entrave la croissance du marché.





Marchés régionaux lucratifs pour la toux chronique









MarketInsights





Augmentation de l'incidence de la toux chronique





La toux chronique est due à l'asthme, au reflux acide de l'estomac et à l'écoulement postnasal. Les conditions telles que l'infection, la bronchite et les maladies pulmonaires sont également susceptibles d'entraîner une toux chronique. La condition telle que l'asthme augmente à travers le monde; on le voit couramment chez les enfants et les adultes. C'est une cause majeure du fardeau croissant de la santé aux États-Unis. Par exemple, selon les données des Centers for Disease Control and Prevention (CDC) publiées en 2019, une personne sur trois souffre d'asthme aux États-Unis. À travers l'Amérique, plus de 25 millions de personnes souffrent d'asthme, ce qui représente environ 8 % des adultes et près de 8,5 % des enfants.





Dans les régions en développement telles que l'Asie-Pacifique et Au Moyen-Orient et en Afrique, la prévalence des maladies chroniques augmente en raison de la pollution et des infections. Les pays de ces régions sont très peuplés. Bien que la toux soit une maladie non transmissible, elle augmente considérablement dans les pays. Plusieurs gouvernements mettent leurs efforts pour contrôler les incidences de la toux chronique dans les pays respectifs. Selon la politique nationale de santé 2017, l'Inde réduit la mortalité prématurée due aux maladies non transmissibles, y compris la toux chronique, d'environ 25 % d'ici 2025.





Au milieu En Afrique de l'Est et en Afrique, les maladies respiratoires sont en augmentation en raison des conditions climatiques. Les pays entourés de desserts sont sujets au risque de maladies respiratoires en raison de la propagation facile des allergènes. Plus de 60 à 70% des patients dans les pays sont diagnostiqués avec des maladies respiratoires. Le tabagisme est une autre cause majeure de toux chronique chez les habitants de la région. Près de 30 % des personnes sont dépendantes du tabagisme, ce qui entraîne une augmentation de l'incidence de la toux chronique.





Drug Class Insights





< p> Sur la base de la classe de médicaments, le marché de la toux chronique est segmenté en antihistaminiques, contorsionnistes, décongestionnants, médicaments combinés, antibiotiques, bloqueurs d'acide et autres classes de médicaments. Le segment des médicaments combinés détenait la plus grande part du marché en 2019 et on estime que le même segment affiche le TCAC le plus élevé du marché au cours de la période de prévision. La croissance du segment est estimée en raison des avantages offerts par les médicaments combinés, tels que l'utilisation de médicaments combinés pouvant cibler le traitement de plusieurs symptômes. De plus, la combinaison de médicaments est largement disponible en tant que médicaments en vente libre.





Marché mondial de la toux chronique, par classe de médicaments - 2019 et 2027





Voyage d'administration Insights





Sur la base de la voie d'administration, le marché de la toux chronique est segmenté en voies d'administration orales, injectables, par inhalation et autres. Le segment oral détenait la plus grande part du marché en 2019. Cependant, on estime que le segment par inhalation enregistre le TCAC le plus élevé du marché au cours de la période de prévision.





Aperçu des canaux de distribution

Sur la base du canal de distribution, le marché de la toux chronique est segmenté en pharmacie hospitalière, pharmacie en ligne et pharmacie de détail. Le segment de la pharmacie hospitalière détenait la plus grande part du marché en 2019. Cependant, on estime que le segment de la pharmacie en ligne enregistrera le TCAC le plus élevé du marché au cours de la période de prévision.





Insights stratégiques





Les stratégies inorganiques sont les stratégies les plus couramment adoptées par les entreprises sur le marché de la toux chronique, ce qui leur permet de se développer leurs empreintes mondiales et leurs portefeuilles de produits et de services. Les acteurs du marché ont également adopté des stratégies organiques telles que la stratégie de lancement de produits pour élargir leur clientèle mondiale, ce qui leur permet également de conserver leur marque à l'échelle mondiale.





Marché mondial de la toux chronique - Par classe de médicaments





  • Antihistaminiques

  • Corticostéroïdes

  • Décongestionnants

  • Médicament combiné

  • Antibiotiques

  • Bloqueurs d'acide

  • Autre classe de médicaments




Marché mondial de la toux chronique - Par voie d'administration



  • Injections

  • Orale

  • Nasale

  • Autre voie d'administration




Marché mondial de la toux chronique - Par canal de distribution





< ul class="tox-checklist">
  • Pharmacie hospitalière

  • Pharmacie en ligne

  • Pharmacie de détail




  • Marché de la toux chronique - par géographie






    • Amérique du Nord




      • États-Unis

      • Canada

      • Mexique



    • Europe

      • France

      • Allemagne

      • Italie

      • Royaume-Uni

      • Espagne


    • Asie-Pacifique (APAC)

      • Chine

      • Inde

      • Corée du Sud

      • Japon< /li>
      • Australie



    • Moyen-Orient et Afrique (MEA)

      • Afrique du Sud

      • Arabie saoudite

      • EAU



    • Amérique du Sud et centrale

      • Brésil

      • Argentine






    Profils des entreprises






    • Novartis AG




    • Teva Pharmaceutical Industries Ltd

    • Glaxo SmithKline plc.

    • Bayer AG,

    • Mylan NV

    • Amneal Pharmaceuticals, Inc.

    • Cipla Inc.

    • Reckitt Benckiser Group plc

    • Sun Pharmaceutical Industries Ltd

    • Aurobindo Pharma Ltd


    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is chronic cough?

    Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. It is caused due to multiple reasons such as infections, asthma, gastro esophageal reflux disease (GERD), among others.

    What are the driving factors for the chronic cough market across the globe?

    The growth of market is likely to grow due to factors such as rising incidences of chronic cough and growing product developments to treat chronic cough are expected to drive the growth of the market. However, product recall is the major factor hindering the market growth.

    What is the average cost of chronic cough medicines?

    The cost of chronic cough medicine starts from US$ 2 and above. The price of medicine depends upon the type of drug, whether it is tablet, syrup, or nasal spray. The generic and OTC drugs are much cheaper compared to the branded and prescribed ones.

    The List of Companies - Chronic Cough Market

    1. Novartis AG
    2. Teva Pharmaceutical Industries Ltd
    3. Glaxo Smith Klineplc.
    4. Bayer AG
    5. Mylan N.V.
    6. Amneal Pharmaceuticals, Inc.
    7. Cipla Inc.
    8. Reckitt Benckiser Group plc.
    9. Sun Pharmaceutical Industries Ltd
    10. AurobindoPharma Ltd

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports